Answers are grounded in this paper and cite their sources.
Background The gonadotropin-releasing hormone (GnRH) stimulation test remains the reference standard for confirming central precocious puberty (CPP), but is invasive and costly. We developed and validated an interpretable machine-learning model differentiating CPP from premature thelarche (PT) using only pre-stimulation information. Methods From 15,385 consecutive outpatients (2020–2026) at a tertiary hospital in northwest China, we analyzed 130 girls with early breast development, a final diagnosis of CPP (n=51) or PT (n=79), and basal luteinizing hormone (LH) and follicle-stimulating hormone (FSH) measurements. Seventeen candidate pre-stimulation predictors were reduced by LASSO regression. Six algorithms were compared by repeated stratified 5-fold cross-validation, with feature selection, imputation, and standardization refitted inside each training fold (fully nested validation). The final model was evaluated by out-of-fold AUC, calibration, decision-curve analysis, SHAP, and a pre-specified two-threshold triage. Results The most frequently selected predictors were age, basal FSH, and the basal LH/FSH ratio. Penalized logistic regression achieved a nested AUC of 0.813 (pooled out-of-fold 0.805, 95% CI 0.729–0.876), indistinguishable from non-linear comparators. Age alone achieved 0.818; adding hormonal variables raised the AUC to 0.855 and, at matched 90% sensitivity, specificity from 0.569 to 0.627. Calibration was moderate (slope 0.600). Under the triage rule, 38.5% of girls fell below the rule-out threshold (negative predictive value 0.900; 5 of 50 with CPP) and 21.5% exceeded the rule-in threshold (positive predictive value 0.750); an estimated 60.0% could potentially have deferred the stimulation test—a retrospective estimate, not a demonstrated reduction. Discrimination was attenuated at ages 6–8.99 years (AUC 0.707) and stable in a hardened reference-standard subset (n=101; AUC 0.787). Conclusions A parsimonious, hand-computable three-variable model using only pre-stimulation data stratifies girls with early breast development and could potentially defer the GnRH stimulation test in an estimated three-fifths, at the cost of initially assigning 5 girls with CPP to structured surveillance. External multicenter prospective validation with local recalibration is required before clinical use.
No takes yet. Share an insight, caveat, or question.
Da et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: